Cargando…
MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9
Non-small-cell lung cancer (NSCLC) is the main pathological type of lung cancer and has a low overall five-year survival rate. miR-187 has been reported to play major roles in various tumor types. In this study, we explored the impact of miR-187 on NSCLC. qRT-PCR results demonstrated that miR-187 ex...
Autores principales: | Liang, Zhihua, Xu, Jianhui, Ma, Zhancheng, Li, Guihua, Zhu, Wanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961586/ https://www.ncbi.nlm.nih.gov/pubmed/31884893 http://dx.doi.org/10.1080/21655979.2019.1706287 |
Ejemplares similares
-
miR-187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2017) -
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2023) -
miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression
por: Wu, Yingqi, et al.
Publicado: (2020) -
MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
por: Cheng, Zhenshun, et al.
Publicado: (2014) -
Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis
por: Hu, Ying, et al.
Publicado: (2020)